On November 10, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health Inc (HIMS), sold 2,637 shares…
Hims & Hers Health is in the spotlight after reporting third-quarter results that beat revenue expectations. This was driven by…
Morgan Stanley reiterates Equalweight rating on Hims and Hers stock at $40…
Morgan Stanley reiterates Equalweight rating on Hims and Hers stock at $40…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
The end of the earnings season is always a good time to take a step back and see who shined…
Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing…
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates an integrated, proprietary technology platform that manages…
Wondering if Hims & Hers Health is a hidden value gem or already fairly priced? Youre not alone, as plenty…
Were turning bullish on Hims & Hers now that we believe the worst is priced in. Click here to read…
Hims & Hers Health recently reported third-quarter results with revenues of US$598.98 million, net income of US$15.77 million, and impairment…
Boughton Soleil, Officer of Hims & Hers Health Inc [HIMS], filed a Form 144 on November 10, 2025 with the…
Hims & Hers Health (HIMS) received a Form 144 notice for a planned sale of 2,637 Class A shares. The…
Die Aktie von Hims & Hers markiert mit den jüngsten Quartalszahlen einen entscheidenden Wendepunkt und wird dadurch für langfristige Investoren…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Hims & Hers Health, Inc. (NYSE: HIMS) is firmly sustaining its high-growth narrative, as evidenced by its latest quarterly earnings…
Earlier this month, Hims & Hers Health announced updated financial guidance, reported third-quarter earnings, and addressed the upcoming reduction in…
Q3 Earnings Reaction: Recent discussions on X about Hims & Hers Health (HIMS) have centered on the company’s third-quarter earnings,…
Ever wondered whether Hims & Hers Health is actually trading at a bargain or if the excitement has already been…
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has built a business model centered on personalized,…
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…
** Shares of telehealth firm Hims & Hers NYSE:HIMS fall 1.1% to $41.1 premarket** U.S. President Donald Trump, Eli Lilly…
New York (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von Citi:Die Analysten der Citi belassen das Rating für die Aktie von Hims…
Hims & Hers said on its recent earnings call that it’s in active talks with Novo Nordisk to make Wegovy…
On September 30, 2025, JPMorgan Chase & Co. executed a significant transaction by acquiring an additional 15,056,384 shares of Hims…
Citi notes that the Trump administration announced that Eli Lilly (LLY) and Novo Nordisk (NVO) have agreed to significantly lower…
Joe Spector immigrated to the U.S. as a child and co-founded Hims & Hers. There was just one problem.…
Hims Hers Health ($HIMS) stock has been a wild ride lately, as investors struggle to decide whether it’s the…
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 6.9% in the morning session after the company reported third-quarter…
Hims & Hers Health delivered a mixed earnings report and announced a potential Wegovy partnership with Novo Nordisk; the downside…
Less than six months after ending a short-lived partnership, US telehealth firm Hims & Hers (Nasdaq: HIMS) and Danish drugmaker…
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn issued their Q3 2026…
Mission Wealth Management LP acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during…
Arkadios Wealth Advisors purchased a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Teacher Retirement System of Texas boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…
Hims & Hers Health (HIMS) posted strong revenue and earnings growth forecasts, with revenue expected to rise 14.7% per year…
Hims & Hers Health (HIMS) has posted average annual earnings growth of 62.2% over the past five years and current…